Effect of regular terbutaline on the airway response to inhaled budesonide.

Author: BennettJ A, ClarkM M, OborneJ, TattersfieldA E, WildingP J

Paper Details 
Original Abstract of the Article :
The rebound increase in bronchial reactivity and fall in forced expiratory volume in one second (FEV1) following treatment with beta agonists seen in several studies has occurred regardless of concurrent steroid therapy. Little is known about the effect of adding beta agonists to corticosteroids, bu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/thx.51.10.989

データ提供:米国国立医学図書館(NLM)

Beta Agonists and Inhaled Corticosteroids: A Complex Relationship

Asthma is a common respiratory condition characterized by inflammation and narrowing of the airways. Inhaled corticosteroids are a mainstay treatment for asthma, but beta agonists, medications that relax the airways, are often used in conjunction with corticosteroids to provide rapid relief. This study examines the potential interactions between regular terbutaline, a beta agonist, and inhaled budesonide, a corticosteroid, on lung function, symptoms, and bronchial reactivity. The researchers sought to investigate the effects of combining these medications, looking for potential benefits and risks.

A Balancing Act: Navigating the Desert of Asthma Treatment

The study found that regular terbutaline treatment appeared to reduce some of the beneficial effects of inhaled budesonide, suggesting a potential interplay between these medications. It's like trying to maintain a delicate balance in a desert ecosystem, where the introduction of a new element can disrupt the delicate balance. The authors emphasize the need for further research to clarify the optimal use of beta agonists in conjunction with inhaled corticosteroids in the management of asthma.

Managing Asthma: A Personalized Approach to Treatment

This research highlights the importance of tailoring asthma treatment plans to the individual patient. It's like choosing the right tools for a journey through the desert, ensuring that they are appropriate for the specific conditions and challenges. By carefully considering the potential interactions between medications and individual patient needs, healthcare providers can optimize asthma treatment outcomes.

Dr.Camel's Conclusion

This research on the interaction between beta agonists and inhaled corticosteroids is like navigating a complex and ever-changing desert landscape. This study underscores the importance of understanding the subtle interplay between medications and individual patient needs, offering a roadmap for optimizing asthma treatment outcomes.

Date :
  1. Date Completed 1997-01-09
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

8977598

DOI: Digital Object Identifier

10.1136/thx.51.10.989

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.